Completed
In Utero Exposure to SARS-CoV-2 (COVID-19) and Cardiovascular and Metabolic Endpoints in Early Life
NCT04921241
- Conditions
- Cardiovascular Diseases, In Utero SARS-CoV-2 Exposure, Metabolic Diseases, +1 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States